These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33762182)

  • 41. Case 01-2017 - Primary vitreoretinal lymphoma (PVRL): report of a case and update of literature from 1942 to 2016.
    Wang Y; Cheung DS; Chan CC
    Ann Eye Sci; 2017 Jul; 2():. PubMed ID: 30167573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
    DeFilipp Z; Li S; El-Jawahri A; Armand P; Nayak L; Wang N; Batchelor TT; Chen YB
    Cancer; 2017 Aug; 123(16):3073-3079. PubMed ID: 28369839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
    Roth P; Martus P; Kiewe P; Möhle R; Klasen H; Rauch M; Röth A; Kaun S; Thiel E; Korfel A; Weller M
    Neurology; 2012 Aug; 79(9):890-6. PubMed ID: 22895585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
    Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
    World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late relapse in primary central nervous system lymphoma: clonal persistence.
    Nayak L; Hedvat C; Rosenblum MK; Abrey LE; DeAngelis LM
    Neuro Oncol; 2011 May; 13(5):525-9. PubMed ID: 21372070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.
    Kasenda B; Ferreri AJ; Marturano E; Forst D; Bromberg J; Ghesquieres H; Ferlay C; Blay JY; Hoang-Xuan K; Pulczynski EJ; Fosså A; Okoshi Y; Chiba S; Fritsch K; Omuro A; O'Neill BP; Bairey O; Schandelmaier S; Gloy V; Bhatnagar N; Haug S; Rahner S; Batchelor TT; Illerhaus G; Briel M
    Ann Oncol; 2015 Jul; 26(7):1305-13. PubMed ID: 25701456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
    Zhao D; Qian L; Shen J; Liu X; Mei K; Cen J; Wang Y; Li C; Ma Y
    J Cell Mol Med; 2014 Jun; 18(6):1081-6. PubMed ID: 24628986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
    Hashida N; Nakai K; Saitoh N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
    Keane C; Hamad N; Barraclough A; Lee YY; Talaulikar D; Ku M; Wight J; Tatarczuch M; Swain F; Gregory GP
    Intern Med J; 2022 Sep; 52(9):1624-1632. PubMed ID: 34927329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnostics and treatment of primary vitreoretinal lymphoma].
    Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
    Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress in central nervous system lymphomas.
    Wang CC; Carnevale J; Rubenstein JL
    Br J Haematol; 2014 Aug; 166(3):311-25. PubMed ID: 24837460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma.
    Villanueva G; Guscott M; Schaiquevich P; Sampor C; Combs R; Tentoni N; Hwang M; Lowe J; Howard S
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitreoretinal Lymphoma.
    Sobolewska B; Chee SP; Zaguia F; Goldstein DA; Smith JR; Fend F; Mochizuki M; Zierhut M
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary central nervous system lymphomas.
    Batara JF; Grossman SA
    Curr Opin Neurol; 2003 Dec; 16(6):671-5. PubMed ID: 14624075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis.
    Schmitt AM; Herbrand AK; Fox CP; Bakunina K; Bromberg JEC; Cwynarski K; Doorduijn JK; Ferreri AJM; Illerhaus G; Issa S; Schorb E; Zucca E; Hemkens LG; Schandelmaier S; Kasenda B
    Hematol Oncol; 2019 Dec; 37(5):548-557. PubMed ID: 31418878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Updates on Primary Central Nervous System Lymphoma.
    Schaff LR; Grommes C
    Curr Oncol Rep; 2018 Feb; 20(2):11. PubMed ID: 29492682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteria.
    Siegal T
    J Clin Neurosci; 2014 May; 21(5):709-15. PubMed ID: 24725453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.
    Doolittle ND; Korfel A; Lubow MA; Schorb E; Schlegel U; Rogowski S; Fu R; Dósa E; Illerhaus G; Kraemer DF; Muldoon LL; Calabrese P; Hedrick N; Tyson RM; Jahnke K; Maron LM; Butler RW; Neuwelt EA
    Neurology; 2013 Jul; 81(1):84-92. PubMed ID: 23685932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma.
    Holdhoff M; Mrugala MM; Grommes C; Kaley TJ; Swinnen LJ; Perez-Heydrich C; Nayak L
    J Natl Compr Canc Netw; 2020 Nov; 18(11):1571-1578. PubMed ID: 33152700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.